- Home
- INSE vs KZIA Comparison
INSE vs KZIA Comparison
Compare INSE & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSE | KZIA |
|---|---|---|
| Founded | 2002 | 1994 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.3M | 154.5M |
| IPO Year | 2014 | 2002 |
Fundamental Metrics
Financial Performance| Metric | INSE | KZIA |
|---|---|---|
| Price | $5.61 | $12.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $14.00 | ★ $19.50 |
| AVG Volume (30 Days) | 117.7K | ★ 252.2K |
| Earning Date | 05-07-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $199,800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 30.25 | N/A |
| 52 Week Low | $5.35 | $4.86 |
| 52 Week High | $9.95 | $17.40 |
Technical Indicators
Market Signals| Indicator | INSE | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 33.22 | 43.25 |
| Support Level | N/A | $11.39 |
| Resistance Level | $8.42 | $14.79 |
| Average True Range (ATR) | 0.26 | 1.22 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 27.59 | 1.75 |
Price Performance
Historical ComparisonAbout INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.